| Third Quarter Highlights Include the Submission of the Company's iglucose 510(k) to the FDA and Completion of Phase II of its GlucoChip Glucose-Sensing Microchip DELRAY BEACH, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today its third quarter 2011 operational highlights, including FDA submission of its iglucose™ 510(k) ...continued PSID |
Tuesday, November 15, 2011
PositiveID Corporation Announces Third Quarter 2011 Highlights
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment